$1.90
In chiusura: Nov 3 EDT
$1.95
0.052.63%
Pre-mercato: 4:07 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Cardlytics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 5
Stima EPS
$-0.230
Stima dei ricavi trimestrali
$54.54M
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$266.20M
Analizza lo storico degli utili di Cardlytics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
CDLX | Cardlytics | -$0.15 | -$0.23 | — | — | $67.06M | $54.54M | — | — | 11/05/2025 | |
CDLX | Cardlytics | -$0.15 | -$0.27 | -$0.13 | 51.85% | $69.64M | $63.93M | $63.20M | -1.14% | 08/06/2025 | |
CDLX | Cardlytics | -$0.09 | -$0.27 | -$0.21 | 22.22% | $67.61M | $58.07M | $61.90M | 6.59% | 05/07/2025 | |
CDLX | Cardlytics | $0.14 | -$0.20 | $0.00 | 100.00% | $89.17M | $63.63M | $74.00M | 16.29% | 03/12/2025 | |
CDLX | Cardlytics | $0.01 | -$0.24 | -$0.15 | 37.50% | $79.00M | $57.79M | $67.06M | 16.04% | 11/06/2024 | |
CDLX | Cardlytics | -$0.24 | -$0.13 | -$0.15 | -15.38% | $76.70M | $75.37M | $69.64M | -7.61% | 08/07/2024 | |
CDLX | Cardlytics | -$0.25 | -$0.11 | -$0.09 | 18.18% | $64.33M | $71.69M | $67.61M | -5.69% | 05/08/2024 | |
CDLX | Cardlytics | -$0.29 | $0.12 | $0.14 | 16.67% | $82.50M | $89.55M | $89.17M | -0.43% | 03/14/2024 | |
CDLX | Cardlytics | -$0.50 | -$0.01 | -$0.01 | 0.00% | $72.71M | $80.01M | $79.00M | -1.26% | 11/08/2023 | |
CDLX | Cardlytics | -$0.65 | -$0.43 | -$0.24 | 44.19% | $75.41M | $69.54M | $76.70M | 10.30% | 08/01/2023 | |
CDLX | Cardlytics | -$0.38 | -$0.56 | -$0.25 | 55.36% | $67.93M | $65.07M | $64.33M | -1.14% | 05/04/2023 | |
CDLX | Cardlytics | -$0.15 | -$0.46 | -$0.29 | 36.96% | $90.05M | $83.54M | $82.50M | -1.24% | 03/01/2023 | |
CDLX | Cardlytics | -$0.33 | -$0.57 | -$0.50 | 12.28% | $64.98M | $73.90M | $72.71M | -1.62% | 11/01/2022 | |
CDLX | Cardlytics | -$0.39 | -$0.46 | -$0.65 | -41.30% | $58.85M | $76.56M | $75.41M | -1.51% | 08/02/2022 | |
CDLX | Cardlytics | -$0.34 | -$0.55 | -$0.38 | 30.91% | $53.23M | $64.66M | $67.93M | 5.05% | 05/02/2022 | |
CDLX | Cardlytics | -$0.05 | -$0.42 | -$0.15 | 64.29% | $67.08M | $76.58M | $90.05M | 17.59% | 03/01/2022 | |
CDLX | Cardlytics | -$0.16 | -$0.54 | -$0.33 | 38.89% | $46.08M | $62.08M | $64.98M | 4.68% | 11/02/2021 | |
CDLX | Cardlytics | -$0.38 | -$0.39 | -$0.39 | 0.00% | $28.22M | $62.81M | $58.85M | -6.30% | 08/03/2021 | |
CDLX | Cardlytics | -$0.26 | -$0.34 | -$0.34 | 0.00% | $45.51M | $51.46M | $53.23M | 3.44% | 05/04/2021 | |
CDLX | Cardlytics | $0.18 | -$0.03 | -$0.05 | -66.67% | $69.29M | $60.89M | $67.08M | 10.17% | 03/01/2021 |
Cardlytics (CDLX) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-06 | $-0.13 | $-0.27 | 51.8 % |
| Q1 | 2025-05-07 | $-0.21 | $-0.27 | 22.2 % |
| Q4 | 2025-03-12 | $0 | $-0.20 | 100.0 % |
| Q3 | 2024-11-06 | $-0.15 | $-0.24 | 37.5 % |
Cardlytics (CDLX) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-06 | $63.20M | $63.93M | -1.14 % |
| Q1 | 2025-05-07 | $61.90M | $58.07M | 6.59 % |
| Q4 | 2025-03-12 | $74.00M | $63.63M | 16.3 % |
| Q3 | 2024-11-06 | $67.06M | $57.79M | 16.0 % |
FAQ
Quando Cardlytics (NASDAQ:CDLX) riporterà gli utili?
Si prevede che Cardlytics (CDLX) fornisca risultati il novembre 5, 2025. Gli ultimi risultati sono stati pubblicati il agosto 6, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Cardlytics (NASDAQ:CDLX)?
L'EPS effettivo era $-0.13, che superato la stima di $-0.27.
Quali sono state le entrate di Cardlytics (NASDAQ:CDLX)?
Le entrate effettive sono state $63.2M, che mancato la stima di $63.9M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.